ATE331951T1 - Surf2lead - Google Patents

Surf2lead

Info

Publication number
ATE331951T1
ATE331951T1 AT02726250T AT02726250T ATE331951T1 AT E331951 T1 ATE331951 T1 AT E331951T1 AT 02726250 T AT02726250 T AT 02726250T AT 02726250 T AT02726250 T AT 02726250T AT E331951 T1 ATE331951 T1 AT E331951T1
Authority
AT
Austria
Prior art keywords
relates
selected target
surf2lead
binding
generating
Prior art date
Application number
AT02726250T
Other languages
English (en)
Inventor
Axel Dietrich
Ola Engkvist
Ulrich Rester
Li-Hsing Wang
Paul Wrede
Original Assignee
Genetics Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Co Inc filed Critical Genetics Co Inc
Application granted granted Critical
Publication of ATE331951T1 publication Critical patent/ATE331951T1/de

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00—ICT specially adapted for analysing two-dimensional [2D] or three-dimensional [3D] molecular structures, e.g. structural or functional relations or structure alignment
    • G16B15/30—Drug targeting using structural data; Docking or binding prediction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00—ICT specially adapted for analysing two-dimensional [2D] or three-dimensional [3D] molecular structures, e.g. structural or functional relations or structure alignment
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/0068—Means for controlling the apparatus of the process
    • B01J2219/007—Simulation or vitual synthesis
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Theoretical Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medical Informatics (AREA)
  • Immunology (AREA)
  • Evolutionary Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
  • Steroid Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
AT02726250T 2001-05-11 2002-05-10 Surf2lead ATE331951T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29007001P 2001-05-11 2001-05-11

Publications (1)

Publication Number Publication Date
ATE331951T1 true ATE331951T1 (de) 2006-07-15

Family

ID=23114425

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02726250T ATE331951T1 (de) 2001-05-11 2002-05-10 Surf2lead

Country Status (6)

Country Link
US (1) US20040152096A1 (de)
EP (1) EP1388009B1 (de)
AT (1) ATE331951T1 (de)
AU (1) AU2002256737A1 (de)
DE (1) DE60212830T2 (de)
WO (1) WO2002092218A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8236849B2 (en) * 2008-10-15 2012-08-07 Ohio Northern University Model for glutamate racemase inhibitors and glutamate racemase antibacterial agents
CN101736406A (zh) * 2009-11-04 2010-06-16 西华大学 一种通过代谢预测和虚拟筛选发现中药活性成分的方法

Also Published As

Publication number Publication date
WO2002092218A2 (en) 2002-11-21
DE60212830D1 (en) 2006-08-10
EP1388009B1 (de) 2006-06-28
EP1388009A2 (de) 2004-02-11
AU2002256737A1 (en) 2002-11-25
WO2002092218A3 (en) 2003-11-20
US20040152096A1 (en) 2004-08-05
DE60212830T2 (de) 2006-11-09

Similar Documents

Publication Publication Date Title
MXPA03007734A (es) Metodo para la busqueda de una guia de programas electronica.
ATE354573T1 (de) ßPYRAZOLVERBINDUNGEN, DIE SICH ALS PROTEINKINASEINHIBITOREN EIGNENß
GB2379112B (en) Method for acquiring azimuth information
DK1471065T3 (da) Hidtil ukendt 1,2,4-triazolforbindelse
WO2003016321A3 (de) Neue phosphitverbindungen und neue phosphitmetallkomplexe
NL1024261A1 (nl) Preparaten, die een indolinonverbinding bevatten.
WO2003084475A3 (en) INHIBITORS OF THE S100-p53 PROTEIN-PROTEIN INTERACTION AND METHOD OF INHIBITING CANCER EMPLOYING THE SAME
NO20025686D0 (no) Storsekk, samt fremgangsmåte til fremstilling av denne
MXPA03008944A (es) Inhibidores de la procolageno c proteinasa basados en acidos 3-heterociclilpropanohidroxamicos.
DE602004025706D1 (de)
EA200500191A1 (ru) Кристаллический 2,5-дион-3-(1-метил-1h-индол-3-ил)-4-[1-(пиридин-2-илметил)пиперидин-4-ил]-1h-индол-3-ил]-1h-пирролмоногидрохлорид
FI20000013L (fi) Menetelmä ammoniumnitraatin stabiloimiseksi
PL1641731T3 (pl) Sposób wytwarzania 1-oktenu z produktu CRACK-C4
GB2378835B (en) Method for acquiring azimuth information
ATE331951T1 (de) Surf2lead
IS7981A (is) Aðferð til að framleiða örkerfi
WO2005019475A3 (en) Hypoxia-inducible protein 2 (hig2), a novel therapeutic potential target of renal cell carcinoma (rcc)
PL362392A1 (pl) Sposób wytwarzania pochodnych taksanu
MX234329B (es) Metodo para producir n-fosfonometilglicina.
ATE380549T1 (de) Substituierte 1-phenethylpiperidinverbindungen, die unter anderem als analgetika verwendung finden
BR0311278B1 (pt) processo para a extraÇço de um metal bÁsico a partir de um minÉrio ou concentrado contendo cobre e o metal bÁsico.
AU2002216114A1 (en) Focussing of compound libraries using atomic electrotopological values
WO2002012889A3 (en) Focussing of compound libraries according to biological activities or properties
FI20012290L (fi) Menetelmä fenolisen aineen tuottamiseksi puusta
ATE394370T1 (de) Von vitamin d abgeleitete monohalogenvinylverbindungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties